ES2149279T3 - Sistema terapeutico para el tratamiento de la psoriasis. - Google Patents

Sistema terapeutico para el tratamiento de la psoriasis.

Info

Publication number
ES2149279T3
ES2149279T3 ES94924861T ES94924861T ES2149279T3 ES 2149279 T3 ES2149279 T3 ES 2149279T3 ES 94924861 T ES94924861 T ES 94924861T ES 94924861 T ES94924861 T ES 94924861T ES 2149279 T3 ES2149279 T3 ES 2149279T3
Authority
ES
Spain
Prior art keywords
pct
treatment
therapeutic system
sec
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94924861T
Other languages
English (en)
Inventor
Harald List
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2149279T3 publication Critical patent/ES2149279T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE UN SISTEMA TERAPEUTICO PARA APLICACION TOPICA DE SUSTANCIAS ACTIVAS EN EL TRATAMIENTO DE ENFERMEDADES DE LA PIEL QUE INCLUYEN PROLIFERACION DE CELULAS PRONUNCIADAS. EL SISTEMA SE CARACTERIZA POR EL HECHO DE QUE LA SUSTANCIA ACTIVA EN CUESTION ES UN DERIVADO ACEPTABLE FARMACEUTICAMENTE DE LA VITAMINA D 3, CON LA EXCEPCION DE TALES DERIVADOS DE LA VITAMINA D 3, QUE SIRVEN PARA LA REGULACION DEL METABOLISMO DE CALCIO.
ES94924861T 1993-08-21 1994-08-10 Sistema terapeutico para el tratamiento de la psoriasis. Expired - Lifetime ES2149279T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4328217A DE4328217C2 (de) 1993-08-21 1993-08-21 Therapeutisches System zur Behandlung der Psoriasis

Publications (1)

Publication Number Publication Date
ES2149279T3 true ES2149279T3 (es) 2000-11-01

Family

ID=6495752

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94924861T Expired - Lifetime ES2149279T3 (es) 1993-08-21 1994-08-10 Sistema terapeutico para el tratamiento de la psoriasis.

Country Status (11)

Country Link
US (1) US5695778A (es)
EP (1) EP0714304B1 (es)
JP (1) JPH09506331A (es)
AT (1) ATE193651T1 (es)
CA (1) CA2168882A1 (es)
DE (2) DE4328217C2 (es)
DK (1) DK0714304T3 (es)
ES (1) ES2149279T3 (es)
GR (1) GR3034338T3 (es)
PT (1) PT714304E (es)
WO (1) WO1995005829A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711558A1 (en) * 1994-10-21 1996-05-15 Unilever Plc Compositions for topical application to skin, hair and nails
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19736265C2 (de) * 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen
HU226610B1 (en) * 1998-03-04 2009-04-28 Teijin Ltd Activated vitamin d3 emulsion-type lotions
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
CA2424672A1 (en) * 2000-10-23 2002-05-02 Huntsman International Llc High performance sealant formulations based on mdi prepolymers
MXPA03003511A (es) * 2000-10-27 2004-05-04 Leo Pharma As Composicion topica que contiene al menos una vitamina d o un analogo de vitamina de y al menos un corticosteroide.
KR100438254B1 (ko) * 2001-03-29 2004-07-02 아이큐어 주식회사 비타민 ｄ 유사체를 포함하는 매트릭스형 경피흡수제제
WO2004028515A1 (en) * 2002-09-26 2004-04-08 Young-Kweon Choi Matrix type patch for transdermal administration of vitamin d analog and the use thereof
AU2003242464A1 (en) * 2003-06-18 2005-01-04 Hokkaido Technology Licensing Office Co., Ltd. Material for cell adhesion and proliferation
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
EP1917072B1 (en) 2005-06-01 2013-02-27 Stiefel Research Australia Pty Ltd Vitamin formulation
KR20170023776A (ko) 2014-02-26 2017-03-06 루마 세러퓨틱스 인코포레이티드 자외선 광선 치료 장치들 및 방법들
KR20180134856A (ko) 2016-02-09 2018-12-19 루마 세러퓨틱스 인코포레이티드 광선요법에 의해 건선을 치료하기 위한 방법, 조성물 및 장치
US11014119B2 (en) * 2019-02-28 2021-05-25 Kiss Nail Products, Inc. Dispensing lid and container
CN112007039B (zh) * 2019-05-28 2022-05-27 南京睿鹰润泽生物医药科技有限公司 一种包含氟西汀和维生素d3或其衍生物的组合物，及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3666587D1 (en) * 1985-08-02 1989-11-30 Leo Pharm Prod Ltd Novel vitamin d analogues
USRE34692E (en) * 1987-07-09 1994-08-09 Lts Lohmann Therapi-Systeme Gmbh & Co. Kg Transdermal therapeutic system
EP0412110B1 (en) * 1988-04-21 1993-07-07 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
US5532228A (en) * 1990-02-06 1996-07-02 Schering Aktiengesellschaft Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
ATE173401T1 (de) * 1990-09-07 1998-12-15 Wisconsin Alumni Res Found Neue verwendung von 1-alpha-hydroxylierten-19-nor-vitamin-d-verbind ngen zur behandlung von psoriasis
AU656829B2 (en) * 1991-12-26 1995-02-16 Wisconsin Alumni Research Foundation 26, 27-dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same

Also Published As

Publication number Publication date
WO1995005829A1 (de) 1995-03-02
DE59409394D1 (de) 2000-07-13
PT714304E (pt) 2000-11-30
ATE193651T1 (de) 2000-06-15
EP0714304A1 (de) 1996-06-05
JPH09506331A (ja) 1997-06-24
GR3034338T3 (en) 2000-12-29
US5695778A (en) 1997-12-09
EP0714304B1 (de) 2000-06-07
DK0714304T3 (da) 2000-10-16
DE4328217A1 (de) 1995-02-23
CA2168882A1 (en) 1995-03-02
DE4328217C2 (de) 1996-01-11

Similar Documents

Publication Publication Date Title
Calzavara-Pinton et al. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications
AU761947B2 (en) Skin and tissue care and/or treatment agent
ES2164097T3 (es) Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial.
DK0714304T3 (da) Terapeutisk system til behandling af psoriasis
DE69532751D1 (de) Kosmetische, pharmazeutische oder dermatologische Zusammensetzung, sowie die Zusammensetzung Alpha-TNFAntagonisten enthaltend
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
AR012172A2 (es) Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
MXPA04000654A (es) Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
MX9307885A (es) Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos.
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
YU75093A (sh) Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka
DK0785769T3 (da) Terapeutisk vitamin-calcium-kombination i form af en galenisk enhedsdosistablet, fremgangsmåde til fremstilling af denne sa
CA2091200A1 (en) Topical composition for relieving aches and pains
AR026197A1 (es) Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
Nocera et al. Benefits of Avène thermal hydrotherapy in chronic skin diseases and dermatological conditions: An overview
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
DK0737069T3 (da) Deuterede aktive stoffer til transdermal administrering
US3705239A (en) Pain removing compositions and methods
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 714304

Country of ref document: ES